Aprobarbital
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Zakblade2000 (talk | contribs) at 14:35, 13 April 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:35, 13 April 2018 by Zakblade2000 (talk | contribs)
Clinical data | |
---|---|
Other names | aprobarbital, Oramon, allylpropymal, Alurate, 5-isopropyl- 5-allylbarbituric acid |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.908 |
Chemical and physical data | |
Formula | C10H14N2O3 |
Molar mass | 210.23 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Aprobarbital (or aprobarbitone), sold as Oramon, Somnifaine, and Allonal, is a barbiturate derivative invented in the 1920s by Ernst Preiswerk. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1] Aprobarbital was never as widely used as more common barbiturate derivatives such as phenobarbital and is now rarely prescribed as it has been replaced by newer drugs with a better safety margin.
See also: Alphenal
References
- ^ Reddemann H, Turk E. Oramon poisoning in infancy and childhood. Observations on 12 aprobarbital poisonings (German). Das Deutsche Gesundheitswesen. 1966 May 12;21(19):878-81.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|